View Clinical Trial (Medical Research Study)

Safety and Efficacy of AGN 210699 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma - NCT00809848-(Clinical Trial 260116)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Artesia
State:  
CA
Zip Code:
Conditions: Ocular Hypertension - Glaucoma
Purpose: The study will evaluate the safety and efficacy of AGN 210669 ophthalmic solution in comparison with AGN 210669 vehicle and bimatoprost ophthalmic solution dosed once-daily each morning, in subjects with ocular hypertension or primary open-angle glaucoma. Subjects will be followed for 2 weeks.
Study summary:
Criteria: Inclusion Criteria: - Ocular hypertension or primary open-angle glaucoma - Females of non-childbearing potential - Subject requires IOP-lowering therapy in both eyes - IOP ≥ 22 mm Hg and ≤ 34 mm Hg - Has a visual acuity score of 20/100 or better in each eye Exclusion Criteria: - Uncontrolled systemic disease - Active ocular disease - Alteration of existing chronic systemic medications - Known allergy or sensitivity to the study medications - Ophthalmic corticosteroids - Visual field loss which in the opinion of the investigator is functionally significant - History of ocular laser, intraocular surgery, or refractive surgery
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: September 9, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.